PFGIA
MCRB icon

Patriot Financial Group Insurance Agency’s Seres Therapeutics MCRB Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-30
Closed -$2K – 1666
2019
Q4 		$2K Hold
30
– – ﹤0.01% 1133
2019
Q3 		$2K Hold
30
– – ﹤0.01% 1102
2019
Q2 		$2K Hold
30
– – ﹤0.01% 1129
2019
Q1 		$4K Buy
+30
New +$3.66K ﹤0.01% 899

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Patriot Financial Group Insurance Agency's MCRB Position: Q1 2020 in Review

Patriot Financial Group Insurance Agency sold out of Seres Therapeutics (MCRB) in Q1 2020, closing a stake of 30 shares — an estimated $2K sold.

Patriot Financial Group Insurance Agency first reported a position in MCRB in Q1 2019 and held it in 4 quarters. The position peaked at $4K in Q1 2019. 77 funds tracked by Wall St. Rank hold MCRB as of Q1 2020.

  • Patriot Financial Group Insurance Agency reported no remaining Seres Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 30 Seres Therapeutics shares in Q1 2020, an estimated $2K.
  • Patriot Financial Group Insurance Agency first reported a position in Seres Therapeutics in Q1 2019 and held it in 4 quarters.
  • Patriot Financial Group Insurance Agency's Seres Therapeutics position peaked at $4K in Q1 2019.
  • 77 funds tracked by Wall St. Rank held Seres Therapeutics as of Q1 2020.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q1 2020, filed 15 Apr 2020.